Ellagic acid supplementation in women with the poly cystic ovarian syndrome
Phase 3
- Conditions
- Polycystic ovarian syndrome.Polycystic ovarian syndromeE28.2
- Registration Number
- IRCT20141025019669N12
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Women with the poly cystic ovarian syndrome
Exclusion Criteria
Use of contraceptives, glucocorticoids and lipid lowering drugs over the past three months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method